PRR:
- cvac already in phase II/III clinical trial, hopefully a couple of years away from fda approval (fingers crossed).
- based on a technology already approved, with improvements in methodology, hopefully increasing efficacy
- designed for muc-1 cancers, namely ovarian, hopefully others in the future
NRT:
- new laboratory based drug, recently patented
- yet to start human trials, as kbear stated, a decade away from approval
- would most likely target brain cancer
prr vs nrt product differences, page-3
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
-0.010(2.94%) |
Mkt cap ! $480.0M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 33.5¢ | 32.0¢ | $1.703M | 5.215M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 211685 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 279000 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |